<DOC>
	<DOCNO>NCT01841125</DOCNO>
	<brief_summary>Purpose : Evaluation Efficacy Escitalopram Treatment Depression Alzheimer 's Disease Trial Design : A 12-week , randomize , double-blind , parallel-group , placebo-controlled trial open-label , 12-week extension</brief_summary>
	<brief_title>Escitalopram Treatment Depression Alzheimer 's Disease</brief_title>
	<detailed_description>Clinical trial agreement sign party subject process screening . consider suitable evaluate selection / exclusion criterion , randomly assign test group control group ( placebo ) . Assigned test group control subject , prescribe 5mg Escitalopram Placebo . without regard meal , take day . It increase capacity every two week 5mg/day maximum 15mg/day . , treatment 8 week , If n't find side effect , Maintaining capacity . If find side effect , lose capacity . ( 10mg/day ) The test group control subject , receive doctor 's examination inspection six visit 24weeks date randomly assign participant .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>1 ) age 50 2 ) Medical diagnostic criterion must meet standard . 1 . Subject diagnose Alzheimer 's disease accordance NINCDSADRDA Criteria . 2 . Subject three symptom Olin depression ( major depressive episode ) diagnostic criterion . 3. clinical dementia rating ( CDR ) 0.5 2 4 . MMSE 10 ~ 26 ( KMMSE ) 5 . GDS15 â‰¥ 5 point 3 ) When screen , Cholinesterase inhibitor take minimum four week stable subject . 4 ) During clinical trial , Subject change capacity Cholinesterase Inhibitors . 5 ) MRI CT result within 24 month subject Alzheimer 's disease ( AD ) 6 ) Participation clinical trial determine write informed consent form subject actively perform clinical procedure include questionnaire . But subject cognitive dysfunction voluntarily make decision , determine authorize representative participate . 7 ) Subjects must accompany guardian every visit . More three day week , 4 hour per day , spend day guardian . 1 . If take depression drug within 4 week start clinical trial ( e.g . SSRI , Stablon , TCA , wellbutrin , ixel ) 2 . If mental illness ( bipolar disorder , schizophrenia , etc . ) 3 . If serious medical illness ( heart failure , angina pectoris , myocardial infarction , arteriosclerosis , etc . ) psychiatric illness . 4 . Seizures , brain surgery , organic brain disease history organic affective disorder brain MRI , abnormalities brain atrophy . 5 . If history test drug hypersensitivity 6 . If take memantin ( dementia ) 7 . If participate another clinical trial within 3 month . 8 . If pregnant fertile woman , receive sterilization want use effective method contraception . 9 . In laboratory test , kidney failure liver failure . 10 . If history habitual drinking history drug abuse . 11 . Uncontrolled diabetes hypertension . 12 . If determine inappropriate clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Alzheimer 's Disease</keyword>
	<keyword>depressive disorder</keyword>
</DOC>